“…This further suggested that EODF treatment was able to modulate neuroprotective effects related to DEGs, and that its modulation time was mainly focused on the acute and subacute phases after SCI. These included genes that exert beneficial effects on neuroprotection: (1) Socs3 and Arg1 are associated with microglia polarization, with Socs3 potentially inhibiting microglia polarization and thereby exerting a neuroprotective effect (Wu et al, 2016;Aliena-Valero et al, 2021); Arg-1 expression presents an association with the M2 phenotype in microglia, and M2-type microglia are considered a beneficial cell type for recovery from neural injury (Li et al, 2021); (2) Agtr2, Apoe, C3, Cd36, Gabrb2, Il1rn, Nfkbia, and Spp1, which express proteins thought to be involved in exerting anti-inflammatory effects (Marie et al, 2002;Tukhovskaya et al, 2010;Yeung et al, 2018;Huang et al, 2020;Kisucká et al, 2021;Hou et al, 2022;Kaltschmidt et al, 2022;Li and Jakobs, 2022;Shen et al, 2022); (3) Bcl2a1, which exert anti-apoptotic effects (Bedirli et al, 2018); and (4) Cd4 and Serpine1, which are involved in nourishing and promote nerve repair (Calenda et al, 2012;Kofke et al, 2018). (i) The DEGs also included genes involved in nerve injury: (1) Ccl5, Ccl6,Ccr1,Cebpb,Fosl1,Mapk11,Osm,Sphk1,Tnfrsf25,and Trpm2, for which the associated proteins may have been involved in exerting pro-inflammatory effects, including those involved in activating the NF-κB signaling pathway, PI3 kinase/Akt pathway, and CCR1/TPR1/ERK1/2 signaling pathway (Kanno et al, 2005;Li M. et al, 2020;Yan et al, 2020;Komori et al, 2022); (2) Cyba and Sgk1, which promote oxidative stress (Iqbal et al, 2015;Usategui-Martín et al, 2022); (3) Tlr9, which are involved in both pro-inflammatory and induction of oxidative stress, and signal activation, and potentially exacerbate neurodegeneration by ...…”